Reports and Intelligence adds a report titled “Global Ophthalmic Drugs Market (Treatment, type, geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, and Forecast 2013-2020.” The report is a detailed study on the market trends and growth prospects of the global ophthalmic drugs market.
Get detailed report at: http://www.reportsandintelligence.com/ophthalmic-drugs-market
Ophthalmology is branch of medical science, which deals with research and treatment of the diseases and disorders related to the human eye. The increased incidencesof eye disorder has led to an increase in the usage of ophthalmic drugs. Use of combination therapy is also one of the driving factor for the ophthalmic drugs market. Changing lifestyle, technological changes, aging population and increase in healthcare spending are also the key factors driving the growth of the ophthalmic drug market. However, the absence of health insurance and lack of awareness regarding eye disorders & diseases among the population in developing economies acts as a major challenge for the growth of the market.
As per the report, the global ophthalmic drug market is segmented on the basis of treatment, drug type and geography. Different types of ophthalmic drugs are OTC drugs and Prescription drugs. OTC drug has a tremendous growth rate due to increased incidences of dry-eye and ocular allergy. The treatment segment in global ophthalmic drug market includes Dry eye drugs, Anti-inflammatory/allergy/infective drugs, Retinal drugs and Anti-glaucoma drugs. The treatment segment is dominated by the Anti-glaucoma drugs.
The report provides a detailed analysis of the current market trends, factors affecting the market growth, precise market estimations, deep insights on the various geographical regions and drug types with their application. This would further help the global players to design developmental strategies for a sustainable growth....
Please join StudyMode to read the full document